ABSTRACT Increased Troponin I levels and pro-inflammatory cytokines have been reported in most patients undergoing cardiac surgery, ascribed to the type and extent of surgery, reperfusion injury, and the method of myocardial protection. We investigated their levels in patients undergoing on-pump (CCAB) or off-pump (OPCAB) coronary artery bypass surgery and whether these correlated with the extent of myocardial injury. One hundred twenty patients were prospectively randomized to undergo OPCAB (n = 60) or CCAB (n = 60). Hemodynamic and respiratory data, as well as serum CK-MB mass fraction, Troponin I, and interleukin (IL)-6, IL-8, and IL-10 levels, were collected perioperatively. Demographic, hemodynamic, and respiratory parameters were similar between the two groups. Troponin I was significantly lower in the OPCAB than in the CCAB group, either at the end of ischemia, end of surgery, 6-hour and 24-hour postoperatively (4 ± 3, 5 ± 3, 7 ± 5, and 8 ± 3 μg/L, vs. 19 ± 18 , 27 ± 19, 28 ± 13.5, and 33 ± 8.5 μg/L, respectively, p < 0.05). Serum cytokine levels in the OPCAB patients were lower compared to the CCAB group at the end of surgery (32 ± 35, 25 ± 30, and 40 ± 30 pg/ml for IL-6, IL-8, and IL-10 vs. 230 ± 30, 140 ± 70, and 125 ± 50 pg/ml, respectively, p < 0.05). Plasma IL-6 levels correlated with the Troponin I levels at the end of surgery in both groups (r = 0.45, p = 0.01).Thus, OPCAB surgery is associated with reduced levels of Troponin I and activation of cytokines, compared to those in the CCAB group. High levels of these factors could correlate with myocardial damage during coronary artery bypass surgery. This finding warrants further laboratory and clinical confirmation in the future.
Postoperative myocardial damage, as expressed by increased cardio-specific myocardial markers, has been reported in patients undergoing coronary artery bypass grafting (CABG) surgery. 1 The rate and degree depend on the preoperative cardiac status, the type and extent of surgery, the extent of reperfusion injury, the method of myocardial protection, and the usage or no usage of cardiopulmonary bypass (CPB). [1] [2] [3] For many years, the association between immune response and intraoperative myocardial damage during cardiac surgery was thought to be caused mainly by the usage of CPB. 4 Pro-inflammatory cytokines, such as interleukin (IL)-6 or 8, and the antiinflammatory cytokine, IL-10, are activated by the artificial circuit (when CBP is used) and are detected in the circulation throughout surgery. 4, 5 They may play an important role in the development of serious postoperative complications, such as systemic inflammatory response syndrome (SIRS). 6 Other studies have demonstrated the opposite, stating that the immune system is mainly a physiological response to surgery and tissue trauma, independent of the extracorporeal circulation. [7] [8] [9] We assumed that there might be a difference in myocardial damage and immune response modulation between patients undergoing different types of coronary artery bypass surgeries. In order to evaluate these differences, we designed this randomized, prospective study to assess; (1) the differences in myocardial damage between patients undergoing conventional, on-pump CABG (CCAB) versus those undergoing offpump CABG (OPCAB), (2) the differences in the activity of the immune system as expressed by IL-6, IL-8, and IL-10 between these two surgical procedures, (primary goals). The possible correlation between the incidence of myocardial damage and the extent of the immune
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PATIENTS AND METHODS
During the first six months of 2004, 120 consecutive candidates for CABG were enrolled into this prospective, randomized study, which was approved by the institutional Helsinki committee.
Patient selection for CCAB or OPCAB procedure
The potential enrollee needed first to meet the criteria for both OPCAB or CCAB procedures, ruling out patients with a heavily calcified, atherosclerotic, or intra-myocardial coronary or patients with a heavily calcified aorta. Further inclusion criteria were age 40 to 80 years, non-emergent procedure, and left ventricular ejection fraction >25% (as assessed by echocardiography or by angiographic contrast left ventriculography). Exclusion criteria consisted of concomitant debilitating non-cardiac disease, severe peripheral vascular disease (defined by a history of intermittent claudication within walking distance of <100 m), uncontrolled insulindependent diabetes mellitus (preoperative fasting glucose levels >250 g%), fever or infection within one week prior to surgery, recent steroidal or antifibrinolytic therapy (within the last six weeks), or clinically significant laboratory abnormalities (creatinine ≥2.0 mg%, total bilirubin ≥1.5 mg%, hemoglobin ≤10.0 g%, platelet count ≤100,000 cells/mL, clotting abnormality, or white blood cell count <3000 >14,000 cells/mL 3 ). All patients were aspirin-treated preoperatively.
Surgeons who were experienced in the two surgical techniques, and who decided upon the candidate's suitability for them both, evaluated all the candidates clinically and angiographically. The patients then gave written informed consent and were randomized by means of a computer-generated random number table to either CCAB or OPCAB on the day of surgery.
The study design was blinded to the surgeons who assigned the patients to surgery, to the operating room (OR) team, and to the postoperative ward nursing staff. Intraoperative conversion from OPCAB to CCAB could take place if hemodynamic stability could not be achieved during stabilization of the heart, despite aggressive fluid or catecholamine administration, or if the coronary vessels turned out to be small and atheromatotic, calcified, or deeply intramural, thus unsuitable for OPCAB. Intraoperative conversion from CCAB to OPCAB could be carried out if a porcelain aorta was found. Epi-aortic echo was performed only on those with high index of suspicious calcification seen on angiogram, or chest X-rays, or during palpation upon the exposure of the aorta. On both occasions, patients were dropped from the study to eliminate bias and were replaced by others using the same randomization method. Finally the same surgical and anesthesia teams treated all patients.
Induction of anesthesia and monitoring of vital signs
Two 16G peripheral veins, radial artery catheter, surface 5 leads ECG, pulse oximetry, end-tidal CO 2 , and a Swan-Ganz thermodilution pulmonary artery catheter (Baxter Vigilance Monitor Model VGS, Baxter Healthcare Corp., Irvine, CA) were placed prior to surgery.
Standardized anesthesia consisted of IV midazolam 0.07 mg/kg, propofol 1 mg/kg, fentanyl 5-15 μg/kg, lidocaine 1.5 mg/kg, and pancuronium (1.5 mg/kg) for induction, followed by endotracheal intubation. Anesthesia was maintained by infusions of pancuronium (0.1-0.15 mg/kg) and fentanyl (35-50 μg/kg), and dose changes were allowed to keep the patient adequately anesthetized and hemodynamically stable. All patients were ventilated (10 mL/kg tidal volume) with volumeand ratio-preset ventilators. Isoflurane (0.4% to 0.8% inspired concentration) in oxygen was added. The alpha-stat acid base management was adopted when CPB was applied.
The OR temperature was kept between 19
• C and 21
• C. Urinary bladder or rectal temperature was continuously monitored and recorded; body temperature was allowed to drop to 32
• C during extracorporeal bypass; active cooling of the patients was never carried out. Starting from the moment they were placed on the OR table, the patients were warmed to a target temperature of 37
• C throughout surgery and for the following 2 hours, except for the extracorporeal phase of the CCAB procedures, during which the warming system was temporarily deactivated. Warming was applied by means of the Allon TM Thermoregulation system (MTRE ® Advanced Technologies Ltd., Or-Akiva Industrial Park, Israel). 10 
Surgical procedures
CCAB was carried out as previously described. 10 A single heparinization protocol was established for CCAB patients, using 3 mg/kg IV aiming at ACT > 420 seconds. If shorter, heparin was added according to standard tables. Myocardial protection was achieved using intermittent, tepid-blood, retrograde high potassium cardioplegia after initial dose antegrade priming of 800 cc. OPCAB was performed via midline sternotomy during partial heparinization which was achieved using 2 mg/kg (aiming at ACT ∼350 sec).
Mechanical stability of the coronary arteriotomy area was achieved using the Octopus III TM device (Medtronic Inc., Minneapolis, MN), and a soft silicon tourniquet put around the artery obtained hemostasis. No shunts were used. In both procedures, the left anterior descending artery was anastomosed by either the left or the right internal mammary arteries, mostly incorporated in situ. When more grafts were needed, mammary composite grafts, radial arterial, or, occasionally, saphenus vein grafts were used to accomplish revascularization. When required, proximal anastomoses on the aorta were made using partial clamping at the end of the distal anastomoses. At the end of OPCAB, partial reversal of heparin with protamine sulphate was carried out using 50% of the calculated required amount.
Intraoperative autotransfusion and postoperative reinfusion of shed blood were never used. Aprotinin was not used in the study population.
Perioperative data collection
Upon completion of the operation, the patients were transferred to the intensive care unit (ICU) where they were allowed to wake up when they were hemodynamically stable and blood loss from their chest drains was minimal and stable. They were extubated when they were adequately rewarmed and oxygenated (arterial oxygen tension >80 mmHg on an inspired oxygen fraction of 30%).
All perioperative data were recorded in real time by an independent technician, starting at patient's placement on the OR table until 24 hours after surgery. Invasive arterial blood pressure, heart rate, pulmonary artery pressure, and cardiac index were continuously recorded. Wedge pressure and systemic vascular resistance were calculated and assessed at predetermined time points. Dopamine and NTG were used on a routine basis in all our patients. Most of the patients in the CCAB group receive these agents as a preparation for discontinuation of CPB. In the OPCAB group, they were given consistently, to stabilize hemodynamics, during the ischemic period. No other inotropes were used. Inotropic support, fluid management, blood, and blood products requirements were all recorded until patients were discharged from the intensive cardiac care unit; extubation time and ICU stay were recorded as well.
Myocardial injury was checked by determining creatine kinase (CK)-MB mass fraction and Troponin I levels at predetermined time points: induction of anesthesia, immediately after sternotomy, before and upon discontinuation of extracorporeal pulmonary bypass (in CCAB patients) or at the completion of anastomoses (OPCAB), at the end of surgery, 6-hour and 24-hour postoperatively, as previously described. 10 Immunologic modulation was assessed by measuring IL-6, IL-8, and IL-10 serum levels collected at the induction of anesthesia and at the end of surgery. The cytokines were analyzed by an enzymelinked immune absorbent assay (ELISA) using the human IL-6, IL-8, and IL-10 Ultra Sensitive kit (Bio Source International, Camarillo, CA).
Statistical analysis
Power analysis for Troponin I evaluation was performed before for our earlier study 10 by the International Monitoring Company C.A.T.O. Research Israel. Based on the results obtained from that study, the minimal number of patients/group needed to be enrolled in the study was 50. All values are reported as mean ± SD. Parametric variables as demographics (i.e., age, weight, anesthetics, and baseline data), as well as ICU postoperative data were approximated to the normal distribution, and differences between means were analyzed using the 2-tailed Z-test. ANOVA with repeated measures was used to determine changes in vital signs (i.e., hemodynamic and respiratory parameters), CK-MB, and Troponin I levels throughout the study period. The paired t-test was used to analyze differences in mean values of the intra-and postoperative values between the two groups. The non-parametric Mann-Whitney Rank test was applied to determine differences with respect to IL−6, IL-8, and IL−10. The Spearman correlation coefficient was applied to determine the grade of correlation between various interleukins and Troponin I values within each group. The Fisher's exact test was used to analyze categorical data (e.g., type of grafts). All ANOVAs were always followed by the post-hoc Tukey's Honest Significant Difference method. A p-value of ≤0.05 was considered statistically significant.
RESULTS
The CONSORT statement details of the study data (Fig. 1) . The demographic and preoperative clinical data were similar between the two groups ( Table 1 ). The amounts of anesthetics used in the two groups were similar (data not shown) as was the duration of surgery (Table 1 ). Times to extubation and discharge from the hospital were similar between the groups (Table 2 ).
Perioperative vital signs
The patients' hemodynamic data, i.e., mean arterial blood pressure, heart rate, cardiac index, and systemic vascular resistance, were similar between the groups (data not shown) during the perioperative period as was the mean core temperature, with the exception of the relative ischemic periods.
Drugs and blood products usage
There were no differences between the groups with regard to the amounts of catecholamines or nitroglycerin that were administered during the study period ( Table 2 ). The number of packed red cells that were administered postoperatively to the OPCAB patients was significantly lower compared to the CCAB patients (Table 2) .
Cardiac markers and serum cytokines
The CK-MB mass fraction levels are shown in Table 3 . While baseline and post-sternotomy levels were similar among patients from both groups, values tended to increase significantly in the CCAB group, from the end of CPB, as compared to the levels observed in the OPCAB group. These diverse trends lasted for the 24 postoperative hours.
The changes in Troponin I levels were more distinct (Fig. 2) : The uniformly low values recorded during induction and at post sternotomy time points remained the same in the OPCAB group but they increased significantly in the CCAB group from the end of CPB and up to the remaining 24 hours.
The cytokine profiles in the two groups are displayed in Figure 3 . IL-6, IL-8, and IL-10 serum levels were significantly higher at the end of surgery in both groups compared to those recorded during the induction of anesthesia. More interestingly, they were significantly (p < 0.05) lower in the OPCAB group compared to the CCAB group at the end of surgery. When IL-6, IL-8, and IL-10 plasma levels were coupled with the Troponin I in both groups at the end of surgery, a meaningful (though weak, r = 0.45) correlation was found between IL-6 and Troponin but of statistical significance (p < 0.01).
Perioperative complications
There were no occurrences of myocardial infarction during the immediate perioperative period, as assessed by a new appearance of Q-waves, CK-MB mass levels > 50 μg/L, echocardiographic abnormalities, or by unexplained hemodynamic instability. 10 
DISCUSSION
Our current findings confirm earlier evidence of attenuated myocardial injury during OPCAB compared to on-pump CABG. The lower immune response during OPCAB surgery also supports the assumption that the extent of injury is mainly influenced by the use of cardiopulmonary bypass rather than by surgical trauma per se. These findings may suggest a cause-and-effect relation between an inflammatory reaction and the degree of myocardial damage observed in our patients.
OPCAB is a surgical technique that differs from the traditional CCAB by being "minimally invasive" and, as such, by having a "minimal rate of side effects." 2 The relative "minimal invasiveness" feature of OPCAB also could be linked with the improved cardiovascular performance and better outcome associated with it, 11, 12 including minor signs of myocardial damage 13 as well as a potentially reduced physiological response of the immune system. 7 Postoperative augmentation of cardio-specific biomarkers levels (CK-MB and Troponin I), which serve as specific markers of myocardial injury, has been reported in patients undergoing CCAB, but less so during OPCAB surgery. [1] [2] [3] Factors that contribute to the extent of damage in patients undergoing CCAB include the use of cardiopulmonary bypass, different anesthetic protocols, cardioplegic arrest, non-pulsatile coronary blood flow, and the occurrence of myocardial edema. 1 Manipulation and dissection of the myocardium for intra-myocardial artery exposure, local occlusion of the coronary circulation, and reperfusion injury also may induce myocardial damage during OPCAB, and the subsequent release of CK-MB and Troponin I. 1,2 Our current findings indicate that there is a relatively minor rise in Troponin I and CK-MB associated with OPCAB compared to CCAB. Cardiopulmonary bypass is known to induce deleterious effects, both locally and systemically. These include a systemic inflammatory response induced by interleukins and free radicals and the activation of myocardial neutrophils, each factor leading to single organ 14 or multiple organ damage. 15 Cardiac surgeryassociated altered immune response and perioperative myocardial damage have been mainly attributed to the use of an extracorporeal circuit. 5, 15 A close correlation also was found between the length of surgery and cross-clamp time and the degree of myocardial damage and serum IL levels. 6 A recent study has shown, however, that the immune system is activated mainly as a physiological response to surgery and tissue trauma, independently of the extracorporeal circulation. 9 Our findings support the notion that OPCAB surgery has minimal deleterious effects compared to those induced by the extracorporal circuit, possibly via a subtle activation of the immune response system.
The cross-relation between inflammation and myocardial injury has been recognized for more than 50 years and continues to be a topic of investigation. 16 IL-6 causes neutrophil-induced injury to myocytes via an increased expression of intracellular adhesion molecule-1. 17 In their in vitro experiments, Finkel et al. demonstrated that IL-6 can act as a cardiac depressant and may be involved in the occurrence of stunned myocardium. 18, 19 According to Kinugawa et al., IL-6 produces a nitric oxide-mediated reduction in calcium flux and thus depresses the contractility of ventric- ular myocytes. 20 Subsequently, pro-inflammatory cytokines can hamper myocardial function and may contribute to perioperative myocardial damage. This could be involved in the pathogenesis of stroke after CABG 14 and may be associated with a poorer postoperative pulmonary outcome. 21 Our study, however, bears with it several limitations. First, while our rationale for and analysis of the data we collected is statistically convincing, and while the authors are not convinced that longer or more technically challenging surgery causes more tissue damage and inflammation (OPCAB could well be considered as such as well), our statements are not based on a multivariate modeling to analyze other factors that could be influencing the changes, which, if done, could have possibly shed light on alternative mechanism(s) of damage. The issue of association and causality was a major question in our study; it remained unanswered and we suggest further investigation of this issue.
Also, ILs probably should have been measured after 24 hours from surgery and within 2-3 days afterwards; future studies are recommended to do so. We also wish to note that the study investigates process variables rather than actual outcome, thus more extensive studies are warranted. In addition, we did not evaluate cardiac output or SVR in the OPCAB group during the distal anastomoses time due to technical reasons, since we used the Baxter Vigilance System, which is very sensitive to dramatic hemodynamic changes so that it automatically recalibrates during the manipulation of the heart. Sadony et al. suggested that the elevation of serum Troponin I throughout cardiac surgery might indicate late complicated prognosis. 3 The time limit of our study protocol and our not proceeding to do histopathological examinations precluded our assessment of late outcome and of excluding local injury to the myocardium, even in patients with low serum Troponin I levels. We also could not exclude local injury to the myocardium, since our protocol does not call for additional tests after our patients' discharge from hospital or for the obtaining of myocardial biopsies for histopathological tests. Indeed, the protocol does not aim at assessing clinical correlations between Troponin or cytokines levels, complication rates or outcomes of any type. We are unable, therefore, to show the clinical significance of our laboratory findings, however informative and clinically interesting as they may have been. Finally, the correlation between the cytokines and ILs is weak (r = 0.45), although there is a statistical significance. We are currently designing a study in which the induction of cytokine activity will be blocked in patients undergoing OPCAB and CCAB in order to gain better understanding into correlation between the activity of the immune system and myocardial damage.
In conclusion, we demonstrated low levels of Troponin I and of CK-MB and a lower inflammatory response in OPCAB patients compared to CCAB patients. We suggest that there is a cause-and-effect relationship between them, although the results of our study were only partly conclusive. Additional large-scale studies are needed to substantiate our findings and further assess the role of other factors (e.g., epinephrine) on the outcome of patients undergoing CCAB versus OPCAB.
